FDA Authorized Second Booster for Americans 50+ Without Consulting With Its Vax Panel

by Veronika Kyrylenko
Reprinted with permission from TheNewAmerican.com

On Tuesday, the FDA authorized Americans who are 50 years of age and older to receive a second booster of the Covid shot from either Pfizer-BioNTech or Moderna. The move comes after the Biden administration, disregarding the most basic “scientific” decorum and procedures, was reported to offer older Americans a fourth dose of the Covid vaccine. By fall, younger Americans will likely be able to get their second booster, too.

The news of the administration’s planning to make yet another dose available to the public was first reported by The New York Times over the weekend.

The article reads,

“Federal health officials have hotly debated the way forward, with some strongly in favor of a second booster now and others skeptical. But they have apparently coalesced around a plan to give everyone aged 50 and up the option of an additional shot in case infections surge again before the fall.”

There’s a troubling caveat in that decision: it seems to have been made by the administration without discussion with the U.S. Food and Drug Administration’s (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) “independent” panels. Meaning, the Biden administration is releasing the fourth vaccine booster without any public deliberation on the matter. Read Full Article >